Key result
Among perinatally HIV-infected adolescents, 48% and 24% had coronary artery and abdominal aorta PDAY scores ≥1, respectively, indicating increased cardiovascular risk driven by HIV severity and PI use.
Why the study?
What is the aggregate atherosclerotic cardiovascular disease risk, as measured by PDAY scores, among perinatally HIV-infected adolescents?
Cohort (n=165)
What is the aggregate atherosclerotic cardiovascular disease risk, as measured by PDAY scores, among perinatally HIV-infected adolescents?
A substantial proportion of perinatally HIV-infected youth have high PDAY scores indicating increased atherosclerotic cardiovascular disease risk, which is predicted by HIV severity and boosted protease inhibitor use.
May warrant enhanced ASCVD surveillance in perinatally HIV-infected youth; hypothesis-generating for severity- and PI-driven progression.
BACKGROUND: Perinatally HIV-infected adolescents may be susceptible to aggregate atherosclerotic cardiovascular disease risk, as measured by the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) coronary arteries and abdominal aorta risk scores, as a result of prolonged exposure to HIV and antiretroviral therapy. METHODS AND RESULTS: Coronary arteries and abdominal aorta PDAY scores were calculated for 165 perinatally HIV-infected adolescents, using a weighted combination of modifiable risk factors: dyslipidemia, cigarette smoking, hypertension, obesity, and hyperglycemia. Demographic and HIV-specific predictors of scores ≥1 were identified, and trends in scores over time were assessed. Forty-eight percent and 24% of the perinatally HIV-infected adolescents had coronary arteries and abdominal aorta scores ≥1, representing increased cardiovascular disease risk factor burden. Significant predictors of coronary arteries scores ≥1 included male sex, history of an AIDS-defining condition, longer duration of use of a ritonavir-boosted protease inhibitor, and no prior use of tenofovir. Significant predictors of abdominal aorta scores ≥1 included suppressed viral load, history of an AIDS-defining condition, and longer duration of boosted protease inhibitor use. No significant changes in coronary arteries and abdominal aorta risk scores were observed over the 4-year study period. CONCLUSIONS: A substantial proportion of perinatally HIV-infected youth have high PDAY scores, reflecting increased aggregate atherosclerotic cardiovascular disease risk factor burden. High scores were predicted by HIV disease severity and boosted protease inhibitor use. PDAY scores may be useful in identifying high-risk youth who may benefit from early lifestyle or clinical interventions.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2013) conducted a cohort in Perinatally HIV infection (n=165). Perinatal HIV infection and antiretroviral therapy was evaluated on Coronary arteries and abdominal aorta PDAY scores ≥1. Among perinatally HIV-infected adolescents, 48% and 24% had coronary artery and abdominal aorta PDAY scores ≥1, respectively, indicating increased cardiovascular risk driven by HIV severity and PI use.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: